[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100335411":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":20,"studyPopulation":13,"armGroups":21,"interventions":38,"overallOfficials":53,"centralContacts":67,"locations":73,"responsibleParty":91,"collaborators":13,"id":94,"slug":13,"hasResults":95,"nctId":96,"briefTitle":97,"officialTitle":98,"acronym":13,"eligibilityCriteria":99,"healthyVolunteers":95,"sex":100,"minAge":101,"maxAge":13,"enrollmentInfo":102,"targetDuration":13,"studyType":105,"phases":106,"briefSummary":108,"conditions":109,"keywords":13,"overallStatus":76,"whyStopped":13,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},{"fullName":5,"class":6},"Tanta University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Number of patients eith radiological and clinical improvement","Number of patients eith radiological and clinical improvement after cycles of chemotherapy","6 months",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":13,"primaryPurpose":17,"observationalModel":13,"timePerspective":13,"maskingInfo":18},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":19,"maskingDescription":13,"whoMasked":13},"NONE","The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump Inhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma to compare the difference in efficacy.",[22,28,33],{"label":23,"type":24,"description":25,"interventionNames":26},"CHOP","ACTIVE_COMPARATOR","CHOP only",[27],"Drug: CHOP",{"label":29,"type":24,"description":30,"interventionNames":31},"CHOP Plus Lanzoprazole","CHOP Plus Lanzoprazole 60 mg",[32],"Drug: CHOP Plus Lanzoprazole",{"label":34,"type":24,"description":35,"interventionNames":36},"CHOP Plus Famotidine","CHOP Plus Famotidine 40 mg",[37],"Drug: CHOP Plus Famotidine",[39,44,49],{"type":40,"name":23,"description":25,"armGroupLabels":41,"otherNames":42},"DRUG",[23],[43],"CHOP protocol",{"type":40,"name":29,"description":45,"armGroupLabels":46,"otherNames":47},"CHOP plus Lanzoprazole 60 mg",[29],[48],"CHOP Plus Lanzoprazole 60",{"type":40,"name":34,"description":35,"armGroupLabels":50,"otherNames":51},[34],[52],"CHOP Plus Famotidine 40",[54,58,61,64],{"name":55,"affiliation":56,"role":57},"Sahar K Hegazy, Prof","Clinical pharmacy Department- Tanta University","PRINCIPAL_INVESTIGATOR",{"name":59,"affiliation":56,"role":60},"Sahar M El-Haggar, prof","STUDY_DIRECTOR",{"name":62,"affiliation":63,"role":60},"Suzan A Alhassanin, Ph D","Clinical Oncology Department-Menoufia University",{"name":65,"affiliation":66,"role":57},"Eman I A El berri, Msc","Clinical pharmacy Department-Tanta University",[68],{"name":69,"role":70,"phone":71,"phoneExt":13,"email":72},"Sherief Abd-Elsalam, MD","CONTACT","00201147773440","sheriefabdelsalam@yahoo.com",[74],{"facility":75,"status":76,"city":77,"state":13,"zip":13,"country":78,"countryCode":79,"cosmosGeoPoint":80,"geoPoint":85,"contacts":86},"Sherief Abd-Elsalam","RECRUITING","Cairo","Egypt","EG",{"type":81,"coordinates":82},"Point",[83,84],31.24967,30.06263,{"lat":84,"lon":83},[87],{"name":88,"role":70,"phone":89,"phoneExt":13,"email":90},"Sherief Abd-elsalam, lecturer","00201000040794","Sherif_tropical@yahoo.com",{"type":92,"investigatorFullName":75,"investigatorTitle":93,"investigatorAffiliation":5,"oldNameTitle":13,"oldOrganization":13},"SPONSOR_INVESTIGATOR","PhDTropical Medicine","100335411",false,"NCT03647072","PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy","Comparative Clinical and Biochemical Study Evaluating the Effect of Proton Pump I Nhibitors Versus Histamine 2 Receptor Antagonists as an Adjuvant With Chemotherapy in Patients With Non-hodgkin Lymphoma.","Inclusion Criteria:\n\n* DLBCL Lymphoma subtype --No comorbid disease\n\nExclusion Criteria:\n\n* Pregnancy\n* Peptic ulcer\n* Severe cardiac disease\n* Osteoporosis","ALL","18 Years",{"count":103,"type":104},60,"ESTIMATED","INTERVENTIONAL",[107],"PHASE3","The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.",[110],"Lymphoma","2018-08-23",{"date":113,"type":114},"2018-08-27","ACTUAL",{"date":116,"type":114},"2018-08-01",{"date":118,"type":104},"2027-12",{"name":75,"class":6},1]